Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

AN2 Therapeutics, Inc. (ANTX) Insider Traders

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$2.15 -$0.08 (-3.59%)
$2.06
$2.25
$1.91
$22.22

  • NUMBER OF INSIDERS BUYING
    (LAST 12 MONTHS)

    1

  • NUMBER OF INSIDERS SELLING
    (LAST 12 MONTHS)

    6

  • AMOUNT OF INSIDERS BUYING
    (LAST 12 MONTHS)

    $16.00 M

  • AMOUNT OF INSIDERS SELLING
    (LAST 12 MONTHS)

    $10.23 M

AN2 Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price		 Total Transaction Shares Held After Transaction Transaction Date Filing Date Details
Zakrzewski Joseph S

director

 Sell 100,000 @ $19.11 $1.91 M 405,880 01/18/2024 01/19/2024
Aziz Kabeer

director

 Sell 84,093 @ $19.65 $1.65 M 1,995,958 01/16/2024 01/18/2024
Aziz Kabeer

director

 Sell 15,907 @ $19.65 $312,573 377,542 01/16/2024 01/18/2024
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 84,093 @ $19.65 $1.65 M 1,995,958 01/16/2024 01/18/2024
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 15,907 @ $19.65 $312,573 377,542 01/16/2024 01/18/2024
Readnour Robin Shane

director

 Sell 719 @ $21.91 $15,753 485,073 01/12/2024 01/17/2024
Readnour Robin Shane

director

 Sell 706 @ $21.92 $15,476 414,788 01/12/2024 01/17/2024
Readnour Robin Shane

director

 Sell 1,800 @ $21.92 $39,456 485,792 01/10/2024 01/12/2024
Readnour Robin Shane

director

 Sell 1,869 @ $21.93 $40,987 415,494 01/10/2024 01/12/2024
Krause Kevin Michael

Chief Strategy Officer

 Sell 7,417 @ $20.14 $149,367 1,914 01/09/2024 01/11/2024
Krause Kevin Michael

Chief Strategy Officer

 Sell 2,583 @ $20.12 $51,967 1,914 01/02/2024 01/04/2024
Easom Eric

CEO

 Sell 2,777 @ $20.09 $55,802 2,130 01/02/2024 01/04/2024
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 1,522 @ $16.15 $24,574 2,080,051 11/14/2023 11/16/2023
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 288 @ $16.15 $4,650 393,449 11/14/2023 11/16/2023
Aziz Kabeer

director, 10 percent owner:

Sell 1,522 @ $16.15 $24,574 2,080,051 11/14/2023 11/16/2023
Aziz Kabeer

director, 10 percent owner:

Sell 288 @ $16.15 $4,650 393,449 11/14/2023 11/16/2023
Aziz Kabeer

director, 10 percent owner:

Sell 4,770 @ $16.07 $76,654 2,081,573 10/02/2023 10/03/2023
Aziz Kabeer

director, 10 percent owner:

Sell 902 @ $16.07 $14,495 393,737 10/02/2023 10/03/2023
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 4,770 @ $16.07 $76,654 2,081,573 10/02/2023 10/03/2023
Adjuvant Global Health Technology Fund, L.P.

10 percent owner

 Sell 902 @ $16.07 $14,495 393,737 10/02/2023 10/03/2023

AN2 Therapeutics, Inc. Congressional Trades History

Member of congress Current Price Type Trade Data Date Filed Date Traded

AN2 Therapeutics, Inc. Insider Trading Activity - Frequently Asked Questions

  • Q.Who is on AN2 Therapeutics, Inc.'s Insider Roster?

    A. The list of insiders at AN2 Therapeutics, Inc. includes RA CAPITAL MANAGEMENT, L.P., Aziz Kabeer, Adjuvant Global Health Technology Fund, L.P., Easom Eric, Krause Kevin Michael, Readnour Robin Shane, Zakrzewski Joseph S.

  • Q.How much insider selling is happening at AN2 Therapeutics, Inc.?

    A. Insiders have sold a total of 565,631 AN2 Therapeutics, Inc. shares in the last 12 months for a total of 10.23 M sold.

  • Q.Which AN2 Therapeutics, Inc. insiders have been selling company stock?

    A. The following insiders have sold AN2 Therapeutics, Inc. shares in the last 12 months: Aziz Kabeer ($3.98 M), Adjuvant Global Health Technology Fund, L.P. ($3.98 M), Easom Eric ($55,802), Krause Kevin Michael ($201,334), Readnour Robin Shane ($111,672), Zakrzewski Joseph S ($1.91 M),

  • Q.How much insider buying is happening at AN2 Therapeutics, Inc.?

    A. Insiders have purchased a total of 1.78 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 16.00 M sold.

  • Q.Which AN2 Therapeutics, Inc. insiders have been buying company stock?

    A. The following insiders have purchased AN2 Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($16.00 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.